title: The effectiveness of the confidential unit exclusion option.
abstract: BACKGROUND
  The confidential unit exclusion (CUE) option is intended to reduce human immunodeficiency virus (HIV) transmission by excluding donors newly infected with HIV who have not yet developed HIV antibody (window-period donors); however, its efficacy in excluding window-period donors has not been evaluated.
  
  
  METHODS
  The use of the CUE option was studied among the donors of 3.7 million units at 18 American Red Cross blood services regions during 1991 and 1992 and among 322 previously HIV-1-seronegative donors who subsequently donated a seropositive unit between 1987 and 1990 at 40 United States blood centers. These seroconverting donors had previously been shown to be highly likely to donate during their window period.
  
  
  RESULTS
  On the basis of data from these two populations, it was estimated that only 3 to 5 percent of units donated by window-period donors were not transfused because of the CUE option, that 0.4 percent of all donations were from donors who confidentially excluded their blood from transfusion, and that donors who confidentially excluded their blood were 21 times more likely to be HIV antibody-positive than donors who did not use the CUE option. It is estimated that, if all US blood centers used the CUE option, a total of 2 to 17 otherwise acceptable units donated by window-period donors would not be transfused annually.
  
  
  CONCLUSIONS
  Although donors who confidentially exclude their blood from transfusion are 21 times more likely to have HIV antibody, the rarity of window-period donors and the infrequency of confidential exclusion by window-period donors cause the CUE option to have minimal impact on transfusion safety.
authors.affiliation: Division of HIV/AIDS, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: L R
authors.initials: LR
authors.lastname: Petersen
authors.forename: E
authors.initials: E
authors.lastname: Lackritz
authors.forename: W F
authors.initials: WF
authors.lastname: Lewis
authors.forename: D S
authors.initials: DS
authors.lastname: Smith
authors.forename: G
authors.initials: G
authors.lastname: Herrera
authors.forename: V
authors.initials: V
authors.lastname: Raimondi
authors.forename: J
authors.initials: J
authors.lastname: Aberle-Grasse
authors.forename: R Y
authors.initials: RY
authors.lastname: Dodd
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission*; D001782:Blood Donors; D001803:Blood Transfusion / Q000523:psychology* / Q000592:standards; D003219:Confidentiality; D018562:Disease Transmission, Infectious; D006801:Humans